What is DaVita's market cap?

DaVita (DVA) has a market capitalization of $14.45B as of June 15, 2026. Market cap is the total market value of the company's outstanding shares (share price × shares outstanding), shown here in US dollars (USD).

How is DaVita's market cap calculated, and what currency is it in?

Market capitalization is calculated by multiplying DaVita's share price by its total shares outstanding. Although DaVita reports its financial statements in USD, market cap on this page is shown in US dollars (USD) for comparability with other companies.

What is the highest market cap DaVita has reached?

DaVita (DVA) reached its all-time high market cap of $18.26B on April 24, 2015, based on daily closing values in our history.

What is the lowest market cap DaVita has reached?

DaVita (DVA) recorded its all-time low market cap of $1.19B on April 16, 2003 in the available daily history.

Is DaVita's market cap above or below its 5-year average?

At $14.45B, DaVita's market cap is currently above its five-year average of $10.94B.

What was DaVita's market cap in 2025?

DaVita (DVA) ended 2025 with a market cap of $10.01B.

What was DaVita's market cap in 2026?

DaVita (DVA) ended 2026 with a market cap of $14.45B.

DaVita (DVA) Market Cap History

Current

$14.45B

As of Jun 15, 2026

5-Year Average

$10.94B

All-Time High

$18.26B

Apr 24, 2015

All-Time Low

$1.19B

Apr 16, 2003

Market cap daily chart for DaVita (DVA)

Jun 16, 2021 – Jun 15, 2026 · 1,255 trading days

Market Cap growth chart for DaVita (DVA) from 1995 to 2026

Latest: +44.3%

Market Cap history table for DaVita (DVA) from 1995 to 2026


2026	$14.45B	+44.3%	+$4.44B	Jun 15, 2026	May 5, 2026
2025	$10.01B	-23.3%	−$3.04B	Dec 31, 2025	Feb 11, 2026
2024	$13.05B	+33.7%	+$3.29B	Dec 31, 2024	Feb 13, 2025
2023	$9.76B	+36.4%	+$2.61B	Dec 31, 2023	Feb 14, 2024
2022	$7.16B	-42.8%	−$5.35B	Dec 31, 2022	Feb 22, 2023
2021	$12.51B	-13.1%	−$1.89B	Dec 31, 2021	Feb 11, 2022
2020	$14.40B	+24.7%	+$2.86B	Dec 31, 2020	Feb 12, 2021
2019	$11.54B	+30.1%	+$2.67B	Dec 31, 2019	Feb 21, 2020
2018	$8.87B	-35.8%	−$4.96B	Dec 31, 2018	Feb 22, 2019
2017	$13.82B	+5.1%	+$670.05M	Dec 31, 2017	Feb 23, 2018
2016	$13.15B	-12.7%	−$1.92B	Dec 31, 2016	Feb 24, 2017
2015	$15.07B	-8.2%	−$1.36B	Dec 31, 2015	Feb 26, 2016
2014	$16.43B	+20.7%	+$2.82B	Dec 31, 2014	Feb 26, 2015
2013	$13.61B	+25.7%	+$2.78B	Dec 31, 2013	Feb 21, 2014
2012	$10.83B	+48.0%	+$3.51B	Dec 31, 2012	Mar 1, 2013
2011	$7.32B	+2.2%	+$156.52M	Dec 31, 2011	Feb 24, 2012
2010	$7.16B	+17.0%	+$1.04B	Dec 31, 2010	Feb 25, 2011
2009	$6.12B	+16.5%	+$867.38M	Dec 31, 2009	Feb 25, 2010
2008	$5.25B	-13.2%	−$801.59M	Dec 31, 2008	Feb 27, 2009
2007	$6.05B	+0.6%	+$35.51M	Dec 31, 2007	Feb 29, 2008
2006	$6.02B	+14.2%	+$747.50M	Dec 31, 2006	Feb 28, 2007
2005	$5.27B	+29.6%	+$1.20B	Dec 31, 2005	Mar 6, 2006
2004	$4.07B	+37.5%	+$1.11B	Dec 31, 2004	Mar 3, 2005
2003	$2.96B	+32.5%	+$725.62M	Dec 31, 2003	Feb 27, 2004
2002	$2.23B	-1.8%	−$40.21M	Dec 31, 2002	Feb 28, 2003
2001	$2.27B	+59.6%	+$848.29M	Dec 31, 2001	Mar 1, 2002
2000	$1.42B	+162.4%	+$881.36M	Dec 31, 2000	Mar 26, 2001
1999	$542.70M	-77.5%	−$1.87B	Dec 31, 1999	Mar 29, 2000
1998	$2.42B	+26.4%	+$505.16M	Dec 31, 1998	Mar 31, 1999
1997	$1.91B	+26.4%	+$399.39M	Dec 31, 1997	Mar 31, 1998
1996	$1.51B	+20.8%	+$260.47M	Dec 31, 1996	Mar 11, 1997
1995	$1.25B	—	—	Dec 31, 1995	Dec 31, 1995

2026$14.45B+44.3%
2025$10.01B-23.3%
2024$13.05B+33.7%
2023$9.76B+36.4%
2022$7.16B-42.8%
2021$12.51B-13.1%
2020$14.40B+24.7%
2019$11.54B+30.1%
2018$8.87B-35.8%
2017$13.82B+5.1%
2016$13.15B-12.7%
2015$15.07B-8.2%
2014$16.43B+20.7%
2013$13.61B+25.7%
2012$10.83B+48.0%
2011$7.32B+2.2%
2010$7.16B+17.0%
2009$6.12B+16.5%
2008$5.25B-13.2%
2007$6.05B+0.6%
2006$6.02B+14.2%
2005$5.27B+29.6%
2004$4.07B+37.5%
2003$2.96B+32.5%
2002$2.23B-1.8%
2001$2.27B+59.6%
2000$1.42B+162.4%
1999$542.70M-77.5%
1998$2.42B+26.4%
1997$1.91B+26.4%
1996$1.51B+20.8%
1995$1.25B—

Market Cap values are taken from DaVita's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Market Cap at DaVita (DVA)

According to DaVita's latest reported financial statements, the company's latest reported market cap is $10.59B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).

Headline figure above is from the reporting period ending March 31, 2026 (reported May 5, 2026). Chart and table below cover the full reported history back to 1995.

As of the 2026 fiscal year, DaVita (DVA) reported market cap of $14.45B – surged 44.3% year-over-year.

Looking at the 2021–2026 (5 years) stretch, DaVita market cap compounded at +2.9% per year, with mixed annual results across the window.

DaVita market cap declined from $16.43B in 2014 to $14.45B in 2026, a 12.1% drawdown.

2014 marks the peak market cap at $16.43B, with the historical low of $542.70M recorded in 1999.

DaVita Market Cap by Year

DaVita Market Cap 2026: $14.45B

DaVita market cap in 2026 was $14.45B, surged 44.3% from 2025.

DaVita Market Cap 2025: $10.01B

2025's market cap for DaVita came in at $10.01B, declined 23.3% below 2024.

DaVita Market Cap 2024: $13.05B

DaVita posted market cap of $13.05B in 2024, surged 33.7% from 2023.

DaVita Market Cap 2023: $9.76B

In 2023, DaVita reported market cap of $9.76B, surged 36.4% from 2022.

DaVita Market Cap 2022: $7.16B

DaVita market cap in 2022 was $7.16B.

See more financial history for DaVita (DVA).

Sector peers by Market Cap

Healthcare peers of DaVita (DVA), ranked by their latest market cap


Eli Lilly (LLY)	$1.06T
Johnson & Johnson (JNJ)	$567.28B
AbbVie (ABBV)	$391.50B
UnitedHealth Group (UNH)	$373.28B
Merck & Co. (MRK)	$283.78B
AstraZeneca (AZN)	$274.92B
Novo Nordisk (NVO)	$195.17B
Amgen (AMGN)	$189.18B

Frequently asked questions

DaVita (DVA) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

DVA Overview

Counters

Income Statement

Cash Flow

Capital Return

Forecast & Valuation